AstraZeneca AB et al v. MSN Pharmaceuticals, Inc. et al
| AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Nektar Therapeutics |
| MSN Pharmaceuticals, Inc. and MSN Laboratories Pvt. Ltd. |
| 1:2018cv02051 |
| December 26, 2018 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 25, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Sumeet P. Dang for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
Filing 14
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 3/1/2019, at 4:15 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/24/2019. (nms)
|
| Pro Hac Vice Attorney Stuart D. Sender for MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang, filed by Nektar Therapeutics, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, and #13 MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender, Esq., filed by MSN Pharmaceuticals, Inc., MSN Laboratories Pvt. Ltd.. Signed by Judge Richard G. Andrews on 1/24/2019. (nms)
|
| Pro Hac Vice Attorney Aaron P. Maurer for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(ddp) |
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender, Esquire - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: #1 Certification, #2 Certificate of Service)(Rychlicki, Helena) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 1/24/2019 (nms). |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate MSN Laboratories Pvt. Ltd. for MSN Pharmaceuticals, Inc.; Corporate Parent MSN Pharmaceuticals, Inc. for MSN Laboratories Pvt. Ltd. filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Rychlicki, Helena) |
| Filing 10 ANSWER to #1 Complaint, by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: #1 Certificate of Service)(Rychlicki, Helena) |
| Filing 9 NOTICE of Appearance by Helena C. Rychlicki on behalf of All Defendants (Attachments: #1 Certificate of Service)(Rychlicki, Helena) |
| Filing 8 DECLARATION of Mailing regarding service on MSN Laboratories Pvt. Ltd. on December 27, 2018, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 1/3/2019 (nms). |
| Filing 7 SUMMONS Returned Executed by AstraZeneca AB, Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. MSN Pharmaceuticals, Inc. served on 12/27/2018, answer due 1/17/2019. (Silver, Daniel) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Pvt. Ltd. on 12/27/2018; MSN Pharmaceuticals, Inc. on 12/27/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Primecap Management Company, Corporate Parent Fidelity Management and Research LLC, Corporate Parent Vanguard Group for Nektar Therapeutics filed by Nektar Therapeutics. (rwc) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (rwc) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (rwc) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/14/18. Date of Expiration of Patent: 4/4/32.Thirty Month Stay Deadline: 5/14/2021. (rwc) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Filing 1 COMPLAINT - filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2532058.) - filed by AstraZeneca AB, Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(rwc) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
